10 Posts Not To Miss from ISTH 2026, Part 1

ISTH 2026 in Paris gathered an international community of specialists, scientists, and healthcare professionals to explore the newest developments transforming the fields of thrombosis and hemostasis.

The Congress showcased cutting-edge research, clinical advances, and emerging strategies across a wide range of topics, including thromboembolic disorders, anticoagulation, bleeding conditions, and innovative approaches to patient care.

Alongside the scientific program, ISTH 2026 fostered global engagement, with experts sharing key insights, discussing impactful studies and highlighting findings with potential implications for everyday clinical practice.

Below are 10 standout posts from ISTH 2026 highlighting key updates, breakthroughs and discussions from the Congress.

Habib Bennaceur, Senior Vice President of Rare Disease Unit at Novo Nordisk:

“Today I’m excited to be on the ground at ISTH in Paris – one of the most important moments in the haematology calendar, and a valuable opportunity to connect across the rare blood disorder space – with those living with these conditions, as well as colleagues, clinicians, nurses, and other community members.

What I value most about this congress is the energy around our shared sense of purpose.

For ISTH 2026, we’re presenting our own breadth of haemophilia data spanning ages and indications while also learning from the research and perspectives of others who are also exploring ways to deliver more and better for this community.

Despite significant progress, we know that people living with haemophilia still face daily trade-offs between protection from bleeds and the burden of treatment.

Alongside this is the mental load of managing that daily balance – something that is too often overlooked.

Challenging that reality is what continues to drive our passion and focus in this space.

At Novo Nordisk, we recognize that innovation in haemophilia is not only about preventing bleeds.

Our ambition is to give people genuine choice through options that fit within their real lives and reflect their individual needs.

For more than four decades, we have worked alongside this community; listening to their experiences, advancing the science, and deepening our understanding of what it means to live – and live well – with a rare bleeding disorder.

If you’re here in Paris, I encourage you to visit us at booth 907 and connect with our team.

I’m looking forward to the conversations ahead.”

Bianca Constantin, Hematology Resident at Fundeni Clinical Institute Bucharest:

“ISTH 2026 is almost here!

Unfortunately, I won’t be able to join everyone in Paris this year, and I’ll definitely miss being part of what promises to be an outstanding Congress.

As a member of the ISTH Early Career Committee, I would like to wish all participants an inspiring and successful meeting filled with great science, engaging discussions and meaningful new connections.

If you’re attending, don’t miss the activities organized by the Early Career Committee. Make sure to stop by the Early Career Lounge, meet colleagues from around the world, exchange ideas and take advantage of the fantastic networking opportunities throughout the Congress.

Wishing everyone a wonderful week in Paris. I look forward to following the highlights from afar and hope to see many of you soon!”

Louise St. Germain Bannon, Interim Executive Director at International Society on Thrombosis and Haemostasis (ISTH):

“The first morning of ISTH 2026 is off to a fantastic start!

It has been wonderful to see our global community reconnecting in Paris and to spend time with Suzanne Cannegieter, Editor-in-Chief of the Journal of Thrombosis and Haemostasis (JTH), and Mike Makris, Editor-in-Chief of Research and Practice in Thrombosis and Haemostasis (RPTH).

As you’re inspired by the outstanding science being presented this week, I encourage you to consider the ISTH journals for your next manuscript.

They are journals you can trust for rigorous peer review, editorial excellence and a shared commitment to advancing science that improves patient care around the world.

Thank you, Suzanne and Mike, for your leadership and dedication to trusted scientific publishing.

Here are a few moments from the first morning of Congress.

We’re just getting started!”

Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center:

“ISTH 2026 | Paris | Day 1

One of the most valuable lessons from today’s symposium extended beyond devices and clinical trials—it focused on building systems of excellence for pulmonary embolism care.

The discussion highlighted that successful management of acute PE depends not only on selecting the optimal therapy, but also on establishing an organized Pulmonary Embolism Response Team (PERT) with clear objectives, standardized treatment algorithms, multidisciplinary expertise, and continuous outcome assessment.

Key messages included:

• Define institutional goals and treatment pathways before implementing advanced therapies.
• Build a multidisciplinary team integrating hematology, cardiology, emergency medicine, intensive care, radiology, vascular surgery, and cardiac surgery.
• Ensure timely access to appropriate technologies while maintaining evidence-based patient selection.
• Collect clinical outcomes and continuously refine protocols to improve quality of care.
• Above all, recognize that the greatest benefit comes from coordinated expertise rather than technology alone.
• Perhaps the most important message of the session was that excellent outcomes are achieved not by performing more interventions, but by selecting the right patients, making timely multidisciplinary decisions, and delivering the right treatment at the right moment.

As thrombosis care continues to evolve, structured collaboration is becoming just as important as scientific innovation.”

Flora Peyvandi, Professor of Internal Medicine at the University of Milan and former President of ISTH:

“It was a great pleasure to work with future generation of the ISTH in the last two years.”

Cécile Denis, Director of Unit 1176 at INSERM:

“As ISTH 2026 is starting, I would like to repost this announcement for an open position in our lab.

Open for mid-level scientists.

One month an a half before applications close.

Do not hesitate to get in touch.”

Dianne E. van der Wal, Honorary Lecturer at the University of Sydney, Researcher at the ANZAC Research Institute, and Editor at Platelets journal:

“First day of ISTH2026 Very excited to be in beautiful Paris and to hear about latest research in our field:

which ranges from bleeding disorders to cardiovascular diseases e.g. life-threatening blood clots (Thrombosis).

We also study the different blood cells including platelets and the blood vessels (endothelial cells).”

Mary Cushman, University Distinguished Professor and Vice Chair at the University of Vermont:

“This is a wonderful memory of ISTH 2017 in Berlin. The launch of RPTH Journal.

I continue to have travel woes today – my 2nd day trying to get to Paris for ISTH 2026.

Ground stop in PHL due to rain this time.”

Nathan Connell, Clinical Chief of Hematology at Brigham and Women’s Faulkner Hospital:

“Excited to be in Paris representing the Boston.

Bleeding Disorders Center for the opening day of ISTH 2026.

I am looking forward to connecting with colleagues from around the world to discuss the latest science and advances in care for people with inherited bleeding disorders, and to supporting my Mass General Brigham colleagues as they present their work.

I am particularly looking forward to the VWF Scientific and Standardization Committee session as we mark 100 years since Erik von Willebrand’s landmark publication describing the bleeding disorder that would ultimately bear his name.

I am also grateful to the International Society on Thrombosis and Haemostasis (ISTH)Scientific Programme Committee for including important sessions focused on improving the diagnosis and management of bleeding disorders in women and girls.

These discussions are essential to addressing persistent gaps in recognition, evidence, and care.

Looking forward to an engaging and productive meeting.”

Laurent Bertoletti, University Professor and Hospital Practitioner at Jean Monnet University, Saint-Etienne:

“Many thanks to the International Society on Thrombosis and Haemostasis (ISTH) for giving Françoise Gignat-George the opportunity to deliver a memorial lecture in honor of Guy Meyer, former co-leader of our INNOVTE network alongside Patrick Mismetti.

A special thought also goes to our other INNOVTE members who have passed away in recent years: Karine Lacut, Philippe Girard, and Hervé Decousus.”

Stay Updated with the Latest ISTH 2026 Updates on Hemostasis Today.